U.S. Markets closed

Abbvie to acquire Allergan for $63B

Allergan, the maker of Botox will be bought by Abbvie in a cash and stock deal valued at about $63 billion, the companies announced Tuesday. Yahoo Finance discusses with Wedbush Securities Managing Director Sahak Manuelian.